Teva Pharmaceutical Says FDA Approves AirDuo Digihaler Inhalation Powder

Date : 07/15/2019 @ 2:33PM
Source : Dow Jones News
Stock : Teva Pharmaceutical Industries Ltd (TEVA)
Quote : 7.92  -0.12 (-1.49%) @ 12:15AM

Teva Pharmaceutical Says FDA Approves AirDuo Digihaler Inhalation Powder

Teva Pharmaceutical Indu... (NYSE:TEVA)
Historical Stock Chart

3 Months : From Jun 2019 to Sep 2019

Click Here for more Teva Pharmaceutical Indu... Charts.

By Michael Dabaie

 

Teva Pharmaceutical Industries Ltd. (TEVA) said the U.S. Food and Drug Administration approved AirDuo Digihaler Inhalation Powder.

That is a combination therapy digital inhaler with built-in sensors that connects to a companion mobile application for information on inhaler use to people with asthma.

AirDuo Digihaler is indicated for the treatment of asthma in patients aged 12 and older.

The approval of AirDuo Digihaler is based on the review of the supplemental new drug application Teva submitted to the FDA.

 

Write to Michael Dabaie at michael.dabaie@wsj.com

 

(END) Dow Jones Newswires

July 15, 2019 09:18 ET (13:18 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.

Latest TEVA Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.